期刊文献+

中枢神经系统海绵状血管瘤免疫组织化学研究 被引量:2

Immunohistochemical study on central nervous system cavernous hemangiomas
原文传递
导出
摘要 目的 了解中枢神经系统海绵状血管瘤 (CM)的组织结构、血管生成、增殖活性特点。方法 采用ABC法 ,对随机选取的 70例CM标本和 2 0例正常脑组织血管标本进行免疫组织化学染色 ,观察CD34、a 平滑肌抗 (a SMA) ;血管内皮细胞生长因子 (VEGF)、Flt 1、转化生长因子a(TGFa)、Ki6 7的表达 ,并根据染色强度进行对比分析。结果 所有正常脑组织血管中CD34、a SMA呈明显阳性 ,有很好的连续性 ,VEGF、Flt 1、TGFa无明显表达。 70例CM中 ,CD34、a SMA呈阳性表达的分别为 4 7例和 5 0例 ,有明显的不连续性 ;VEGF、Flt 1呈阳性表达的分别为 6 8例和 4 4例 ,弥散分布 ;TGFa呈阳性表达的为 6 8例 ;2种组织中该 5项指标的染色强度差异均有统计学意义 (P <0 0 5 )。Ki6 7在 2种组织中均无明显表达。结论 CM生物学特性主要与其血管壁组织结构的不成熟有关 ,各种血管因子发挥了相当重要的促进作用 ,CM本身的增殖活性有待进一步研究。 Objective To explore the histological structure, angiogenesis, and proliferative activity of central nervous system cavernous hemangiomas. Methods 70 surgical samples of central nervous system cavernous hemangiomas and 20 normal brain vessel samples from patients of epilepsy and open craniocerebral trauma were stained immunohistochemically with CD34, a-SMA;VEGF, Flt-1;and TGFa, Ki67 respectively. A comparison analysis was made according to the expression intensity. Results CD34 and a-SMA were expressed in all the normal control brain vessel tissues in a manner of obvious and continuous staining. VEGF, Flt-1 and TGFa were not expressed obviously in the normal brain tissues. 47 and 50 out of the 70 cavernous hemangioma specimens were positively stained for CD34 and a-SMA respectively,and their expression was less continuous. 68 and 44 out of the 70 cavernous hemangioma specimens were positively stained for VEGF and Flt-1 respectively with diffuse distribution. 68 cavernous hemangioma specimens were positively stained for TGF-a. A significant difference in expression intensity was found for the above 5 factors between the normal control brain tissue and cavernous hemangiomas (all P <0.05). No expression of Ki67 was detected in all samples. Conclusion The biological characteristics of cavernous hemangiomas are mainly relevant to the immaturity of the vessel wall. A series of angiogenic factors play an important role in the development of the lesion. The proliferative activity of the cavernous hemangiomas needs to be studied further.
出处 《中华医学杂志》 CAS CSCD 北大核心 2003年第7期544-547,共4页 National Medical Journal of China
基金 上海市科技发展基金资助项目 ( 0 2 4119112 )
  • 相关文献

参考文献14

  • 1Moyiarity JL, Clatterbuck RE, Rigamomti D. The natural history of cavernous malformations. Neurosurg Clin N Am,1999,10:411-417.
  • 2Uranishi R, Baev NI, Ng PY, et al. Expression of endothelial cell angiogenesis receptors in human cerebrovascular malformations. Neurosurg, 2001,48 :359-368.
  • 3Rothbart D, Awad IA, Lee J, et al. Expression of angiogenic factors and structural protein in central nervous system vascular malformations. Neurosurg, 1996, 38: 915-925.
  • 4Muller AM, Nesslinger M, Skipka G, et al. Expression of CD34 in Pulmonary Endothelial Cells in vivo(1). Pathobiology , 2002, 70:11-17.
  • 5Muller AM, Hermanns MI, Skrzynski C, et al. Expression of the endothelial markers PECAM-1, vWf, and CD34 in vivo and in vitro. Exp Mol Pathol , 2002 , 72:221-229.
  • 6Krum JM, More NS, Rosenstein JM. Brain angiogenesis: varitations in Vascular basement membrane glycoprotein immunoreactivity. Exp Neurol, 1991, 111: 152-165.
  • 7Risau W, Lemmon V. Changes in the vascular extracellular matrix during embryonic vasculogenesis and angiogenesis. Dev Biol, 1988, 125: 441-450.
  • 8Little JR, Awad IA, Jones SC, et al. Vascular pressure and cortical blood flow in cavernous angioma of the brain. J Neurosurg, 1990, 73: 555-559.
  • 9Ferrara N, Herzel WJ. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun, 1989, 161: 851-855.
  • 10Keep RF, Jones HC. Cortical microvessels during brain development: a morphometric study in the rat. Microvasc Res, 1990, 40: 412-426.

同被引文献12

  • 1许良中,杨文涛.免疫组织化学反应结果的判断标准[J].中国癌症杂志,1996,6(4):229-231. 被引量:1365
  • 2张文彩,谭玉珍,王海杰.血小板内皮细胞黏附分子1、细胞间黏附分子3和CD44在体外淋巴管新生中的作用[J].解剖学报,2005,36(1):94-98. 被引量:10
  • 3Gross BA, Lin N, Du R, et al. The natural history of intracranial caveroes malformations [J]. Neurosurg Focus, 2011, 30 (6): E24, 1-7.
  • 4黄理金,冯文峰,漆松涛,等.中枢神经系统海绵状血管畸形的新分类[J].中国为侵袭神经外科杂志,2011,16(11):444—447.
  • 5Zhao Y, Tan YZ, Zhou LF, et al. Morphological observation and in vitro angiogenesis assay of endothelial cells isolated from human cerebral cavernous malformations [J]. Stroke, 2007, 38 (9): 1313-1319.
  • 6Greenberg SM, Vernooij MW, Cordonnier C, et al. Cerebral microbleeds: a guide to detection and interpretation [J]. Lancet Neurology, 2009, 8(2): 165-174.
  • 7Moftakhar P, Hauptman JS, Malkasian D, et al. Cerebral arteriovenous malformations. Part 1: cellular and molecular biology [J]. Neurosurg Focus, 2009, 26(5): E10, 1-15.
  • 8Wustehubea J, Bartol A, Liebler SS, et al. Cerebral cavernous malformation protein CCM1 inhibits sprouting angiogenesis by activating DELTA-NOTCH signaling [J]. PNAS, 2010, 107 (7): 12640-12645.
  • 9Meijer-Joma LB, van der Loos CM, J de Boer O, et al. Microvascular proliferation in congenital vascular malformations of skin and soft tissue[J]. J Clin Pathol, 2007, 60(6): 798-803.
  • 10Mulliken JB, Glowaki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics[J]. Plast Reconstr Surg, 1982, 69(3): 412-422.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部